Specialty Pharmacy

The World Health Organization convened a high-level emergency meeting with government leaders and pharmaceutical company representatives earlier this week to discuss issues surrounding access to experimental Ebola vaccines.

Methotrexate injection treats patients with rheumatoid arthritis, polyarticular-course juvenile idiopathic arthritis, and psoriasis.

Michael Nameth, RPh, MBA, chief executive officer of Aureus Health Services discusses the future path of the company.

New recommendations for the removal of protective gear highlight the need for enhanced technologies.

Sovriad found to have caused significant increase in blood bilirubin levels in deceased patients.

A dendritic cell vaccine for MS attacks the condition early, while preserving the immune system.

A perceived increase in confirmed cases of enterovirus D68 may be attributable to a faster lab test recently put in place by the US Centers for Disease Control and Prevention.

Study finds practices in less competitive markets are able to charge more for services.

Researchers investigate link between a child's genetic makeup and RA risk for mothers.

Federal officials are questioning state policies that mandate a 21-day quarantine of health care workers who treat Ebola patients.

The FDA today granted breakthrough therapy designation to a new treatment for non-small cell lung cancer patients.

Esbriet was granted orphan drug designation and received priority review.

Nanotechnology and shortwave infrared light reveals small tumors and cardiovascular lesions deep inside body.

Hexavalent vaccine protects against diphtheria, tetanus, pertussis, polio, invasive disease caused by Haemophilus influenzae type b, and hepatitis B.

The FDA has approved a new treatment for adults who experience bleeding episodes from a rare and potentially life-threatening form of hemophilia.

Three individuals who were in close contact with an Ebola patient have been placed under quarantine.

Diplomat CEO discusses the company's initial public offering and developing trends in the industry.

Treatment success often depends on the stage of the infection in which they are administered.

Further studies needed to evaluate sleep-related risk factors in IBD, authors say.

Thomas Cohn, chief strategy officer at Armada Health Care, discusses the biggest challenges specialty pharmacies will face over the next 5 years.

Researchers found significant improvements in overall survival and in disease-free survival in patients who received trastuzumab in addition to chemotherapy.

Learn about the strains involved in the current and past epidemics, the features of the Ebola virus, information about aerosolized spread, and treatments in development.

Children infected with enterovirus have a 48% increased risk of developing type 1 diabetes.

Researchers identify mechanisms that trigger hematopoietic stem cell production.

Progress in the fight against an Ebola outbreak has been made on 2 fronts.

Treatment inhibits key process that enables cancer cells to multiply.

Notable outbreaks over the past 2 decades have qualified enterovirus D68 as an emerging pathogen.

Chronic inflammation may lead to development of aggressive form of cancer.

Specialty drug spending predicted to grow by more than 16% annually from 2015 to 2018.